Evidence map›Paper›PMID 30705747›Full record

ReviewClinical and translational allergy2019

Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases.

A Valiulis, J Bousquet, A Veryga, U Suprun, D Sergeenko, S Cebotari, D Borelli, S Pietikainen, J Banys, I Agache and 32 more

Erratum issuedAbstract readReview
In one paragraph

Review in Clinical and translational allergy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease.International journal of chronic obstructive pulmonary disease · 2022
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Effects of extreme meteorological factors on daily mumps cases in Hefei, China, during 2011-2016.Environmental science and pollution research international · 2020
    Article
  18. Review
  19. Helsinki by nature: The Nature Step to Respiratory Health.Clinical and translational allergy · 2019
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

42 authors.

A Valiulis1Department of Public Health, Clinic of Children's Diseases, and Institute of Health Sciences, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.
J Bousquet3MACVIA-France, Fondation partenariale FMC VIA-LR, CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
A VerygaMinister of Health, Vilnius, Lithuania.
U SuprunMinister of Health, Kiev, Ukraine.
D SergeenkoMinister of Labour, Health and Social Affairs, Tbilisi, Georgia.
S CebotariMinister of Health, Labour and Social Protection, Chișinău, Moldova.
D BorelliEuropean Parliament, Perugia, Italy.
S PietikainenEuropean Parliament, Helsinki, Finland.
J BanysLithuianian Academy of Sciences, Vilnius, Lithuania.
I Agache15Faculty of Medicine, Transylvania University, Brasov, Romania.
N E BilloGlobal Alliance Against Chronic Respiratory Diseases (GARD), Joensuu, Finland.
A Bush17Imperial College and Royal Brompton Hospital, London, UK.
I Chkhaidze18Department of Pediatrics, and Iashvili Central Children's Hospital, Tbilisi State Medical University, Tbilisi, Georgia.
L Dubey19Faculty of Postgraduate Education, Lviv National Medical University by Danylo Halytsky, Lviv, Ukraine.
W J Fokkens20Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands.
J Grigg21Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK.
T Haahtela22Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
K Julge23Children's Clinic, Tartu University Institute of Clinical Medicine, Tartu, Estonia.
O KatilovVinnytsa National Medical University by Mykola Pyrogov, Vinnytsa, Ukraine.
N KhaltaevGlobal Alliance Against Chronic Respiratory Diseases (GARD-WHO), Geneva, Switzerland.
M Odemyr26European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
S Palkonen26European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
R Savli26European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
A Utkus27Department of Human and Medical Genetics, Institute of Biomedical Sciences, Vilnius University Faculty of Medicine, Vilnius, Lithuania.
V VilcState Institute of Phtysiopulmonology by Chiril Draganiuk, Chisinau, Moldova.
T Alasevicius1Department of Public Health, Clinic of Children's Diseases, and Institute of Health Sciences, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.
A Bedbrook3MACVIA-France, Fondation partenariale FMC VIA-LR, CHU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
M BewickiQ4U Consultants Ltd, London, UK.
J Chorostowska-Wynimko31Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
E Danila32Clinic of Chest Diseases, Immunology and Allergology, Centre of Pulmonology and Allergology, Institute of Clinical Medicine, Vilnius University Medical Faculty, Vilnius, Lithuania.
A Hadjipanayis33Medical School, European University of Cyprus, Nicosia, Cyprus.
R Karseladze34Tbilisi State University Faculty of Medicine, Tbilisi, Georgia.
V Kvedariene35Clinic of Infectious Chest Diseases, Dermatology and Allergology, Institute of Biomedical Sciences, Institute of Clinical Medicine, Vilnius University Faculty of Medicine, Vilnius, Lithuania.
E Lesinskas36Clinic of ENT and Eye Diseases, Institute of Clinical Medicine, Vilnius University Medical Faculty, Vilnius, Lithuania.
L MünterDanish Commitee for Health Education, Copenhagen East, Denmark.
B Samolinski38Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
S Sargsyan39Institute of Child and Adolescent Health at Arabkir Medical Centre, Yerevan State Medical University, Yerevan, Armenia.
B Sitkauskiene40Department of Immunology and Allergology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
D SomekhEuropean Health Futures Forum (EHFF), Dromahair, Ireland.
L Vaideliene42Clinic of Children's Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
A Valiulis43Department of Rehabilitation, Physical and Sports Medicine, Institute of Health Sciences, Vilnius University Medical Faculty, Vilnius, Lithuania.
P W HellingsEuforea, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOver 1 billion people suffer from chronic respiratory diseases such as asthma, COPD, rhinitis and rhinosinusitis. They cause an enormous burden and are considered as major non-communicable diseases. Many patients are still uncontrolled and the cost of inaction is unacceptable. A meeting was held in Vilnius, Lithuania (March 23, 2018) under the patronage of the Ministry of Health and several scientific societies to propose multisectoral care pathways embedding guided self-management, mHealth and air pollution in selected chronic respiratory diseases (rhinitis, chronic rhinosinusitis, asthma and COPD). The meeting resulted in the Vilnius Declaration that was developed by the participants of the EU Summit on chronic respiratory diseases under the leadership of Euforea.

conclusionThe Vilnius Declaration represents an important step for the fight against air pollution in chronic respiratory diseases globally and has a clear strategic relevance with regard to the EU Health Strategy as it will bring added value to the existing public health knowledge.

Indexed as

Air pollutionAsthmaChronic respiratory diseasesGuidelinesIntegrated care pathwaysmHealthRhinitisVilnius Declaration

Identifiers

PMID30705747
PMCPMC6348633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.